Drug comparisons
Canagliflozin vs Dapagliflozin
Canagliflozin vs Dapagliflozin: Invokana and Farxiga compared as SGLT2 inhibitors for diabetes. Efficacy, side effects, and heart/kidney benefits.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered when choosing an SGLT2 inhibitor for type 2 diabetes patients with overlapping cardiovascular or renal indications.
Bottom line
Canagliflozin and Dapagliflozin offer comparable efficacy as SGLT2 inhibitors, with the preferred choice guided by patient-specific comorbidities and tolerability rather than overall superiority.
All medication comparisons